Zurueck zur Suche

Reporte zur Charge U7124AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

80Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KS 11 WA 8 TX 8 LA 8 CA 7 MO 6 KY 5 AZ 4 VA 3 NJ 2 UT 2 AR 2

VAERS 2134584

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7124aa

schwer
Staat
KS
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
22.02.2022
Beginn
22.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Agitation Cellulitis Erythema Exophthalmos Eye movement disorder Injection site cellulitis Injection site erythema Feeling abnormal Musculoskeletal stiffness Peripheral swelling Pyrexia Seizure Injection site swelling

Symptomtext

Became stiff; Agitation; 'cellulitis' to right calf area; Very faint pinkness noted to right calf; her eyes buldged; EYE MOVEMENT DISORDER; very fussy and inconsolable; Some swelling to the R thigh; pt had a low grade fever; Eyes fluttered a little (she described this as a seizure).; This non-serious case was received from a parent and a nurse via the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2134584-1. The original narrative from the sender is available: "Mother reported that pt had a low grade fever, very fussy and inconsolable, her eyes bulged and became stiff, then her eyes fluttered a little (she described this as a seizure). Some swelling to the R thigh.". In addition: "Seen in ER. Pt put on Amoxicillin for 'cellulitis' to right calf area. Pt was visualized by this reporting nurse on 02.23.2022. Very faint pinkness noted to right calf. There was ink markings noted below knee from where medical staff outlined redness at time seen in ER."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2310719

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

schwer
Staat
TX
Alter
0,5
Geschlecht
F
Eingang
06.06.2022
Impfdatum
23.05.2022
Beginn
24.05.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Body temperature increased Electroencephalogram Fatigue Full blood count Gaze palsy Human rhinovirus test positive Joint contracture Laboratory test Magnetic resonance imaging head Metabolic function test Muscle twitching Respiratory tract congestion Respiratory viral panel Retching Seizure Tremor

Symptomtext

Patient received her vaccines on the morning of 5/23/22. She was in her usual state of health. The following morning as she was breastfeeding mom noted that seemed congested. This was about 6 am. She fell back to sleep after eating. At about 6:30 am she heard her gagging and when she checked on her, her left arm was shaking and the right side of her face was twitching. Her fists were clenched and she was gazing upwards. After she fell asleep and seemed tired. The entire episode lasted approximately 2 minutes. She was taken to the ER for evaluation. After she arrived home she had a low grade temperature of 99. 2 days later she had a temperature of 100.2 . Clinically she seemed well. An upper respiratory panel was positive for human rhinovirus. However, 5 days later she had another episode of seizure and was admitted for further evaluation. She was started on Keppra. She had labwork done including an EEG and MRI of her brain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
3,0
Labordaten
CBC, BMP, and Upper respiratory panel done on 5/26/22 EEG 5/29/22 MRI 5/31/22
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No allergies
Vorherige Impfungen
-

VAERS 2119199

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7124aa

schwer
Staat
KS
Alter
0,2
Geschlecht
M
Eingang
17.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Cyanosis Drug hypersensitivity Electroencephalogram Laboratory test Seizure Seizure like phenomena Viral infection

Symptomtext

Pt. was reported to have 'turned blue' was seen at ER. Possible seizures. Pt transferred to hospital per private vehicle with 'seizure like' activity. Reported by grandmother, that the patient had 'some sort of virus'. She also reported that he had 'a reaction to some sort of medication' that was given at the hospital. Also states he had a seizure while there and team 'checked him for an infection in the brain'

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
2,0
Labordaten
EEG, benadryl, fluids.lab work
Aktuelle Erkrankungen
na-questionable hx of seizures. not diagnosed at time of service
Vorgeschichte
na
Andere Medikamente
na
Allergien
na
Vorherige Impfungen
-

VAERS 1956185

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

moderat
Staat
VA
Alter
-
Geschlecht
F
Eingang
31.03.2022
Impfdatum
06.12.2021
Beginn
15.12.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Pain Vaccination site induration Vaccination site mass

Symptomtext

Child is moving the left leg less; Pain when using the leg; Hard lump on left leg of child at the vaccination site. Not visible until by site but can be felt if the site is palpated; Hard lump on left leg of child at the vaccination site. Not visible until by site but can be felt if the site is palpated; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-Jan-2022 with the following VAERS Primary ID 1956185. The original narrative from the sender is the following: Parent reports hard lump on left leg of child at the vaccination site. Not visible until by site but can be felt if the site is palpated. Parents reports that child is moving the left leg less and is in pain when using the leg. Reports no redness site or respiratory distress or fever. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "child is moving the left leg less", "pain when using the leg" and "hard lump on left leg of child at the vaccination site, not visible until by site but can be felt if the site is palpated". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1956185

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

moderat
Staat
VA
Alter
-
Geschlecht
F
Eingang
31.03.2022
Impfdatum
06.12.2021
Beginn
15.12.2021
Tage bis Beginn
9,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Pain Vaccination site induration Vaccination site mass

Symptomtext

Child is moving the left leg less; Pain when using the leg; Hard lump on left leg of child at the vaccination site. Not visible until by site but can be felt if the site is palpated; Hard lump on left leg of child at the vaccination site. Not visible until by site but can be felt if the site is palpated; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-Jan-2022 with the following VAERS Primary ID 1956185. The original narrative from the sender is the following: Parent reports hard lump on left leg of child at the vaccination site. Not visible until by site but can be felt if the site is palpated. Parents reports that child is moving the left leg less and is in pain when using the leg. Reports no redness site or respiratory distress or fever. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "child is moving the left leg less", "pain when using the leg" and "hard lump on left leg of child at the vaccination site, not visible until by site but can be felt if the site is palpated". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644679

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
AZ
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
12.06.2023
Beginn
12.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Administration site erythema Administration site swelling Swelling Injection site erythema Injection site swelling

Symptomtext

Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh; Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh; Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh; This non-serious spontaneous safety report with reference number # 2307USA011814 (VAERS ID 2644679-1) was received by a partner on 25-JUL-2023 and forwarded to company on 27-JUL-2023 from a health care professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of "Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh". Further information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2644679

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
AZ
Alter
-
Geschlecht
F
Eingang
27.09.2023
Impfdatum
12.06.2023
Beginn
12.06.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Administration site erythema Administration site swelling Swelling Injection site erythema Injection site swelling

Symptomtext

Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh; Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh; Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh; This non-serious spontaneous safety report with reference number # 2307USA011814 (VAERS ID 2644679-1) was received by a partner on 25-JUL-2023 and forwarded to company on 27-JUL-2023 from a health care professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of "Localized swelling,redness within hours of administration not directly at the site given but on the inner thigh". Further information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2608775

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
MO
Alter
0,2
Geschlecht
F
Eingang
04.04.2023
Impfdatum
28.11.2022
Beginn
28.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Infant irritability Injection site erythema Injection site pain Injection site swelling Pyrexia

Symptomtext

Extreme fussiness and unconsolable; Tenderness from the knee to the thigh; after receiving VAXELIS swelling at the injection site on the thigh and fever; Fever/ Pt reported a 100.9 temp; Redness & swelling at the site where vaccine was given/ from knee to the thigh; This non-serious spontaneous safety report with reference number 02320717 was received by a partner on 19-JAN-2023 and forwarded on 20-JAN-2023 from a health care professional. This case was considered non-valid given that no patient identifiers were provided (the reporter was not sure of the patient's age). The reporter did not provide an assessment of the causal relationship between Vaxelis and the event "after receiving VAXELIS swelling at the injection site on the thigh and fever". Further information is expected. FOLLOW-UP Information was received by partner on 25-JAN-2023 and forwarded on 26-JAN-2023 from a health care professional. The case is considered valid (Patient identifiers provided). The reporter assessed the events, "after receiving VAXELIS swelling at the injection site on the thigh", "Redness & swelling at the site where vaccine was given/ from knee to the thigh" and fever/ Pt reported a 100.9 temp" as related to Vaxelis. The reporter did not provide an assessment of the causal relationship between Vaxelis and the events, "Extreme fussiness and unconsolable" and "Tenderness from the knee to the thigh". Follow up information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464148

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
CA
Alter
0,2
Geschlecht
F
Eingang
29.09.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site induration Injection site swelling Peripheral swelling

Symptomtext

Leg is also swollen; Bump at the injection site. Bump is hard; This spontaneous safety report, with reference number 2022SA261502, was received on 21-JUL-2022, from a health care professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the events: "Bump at the injection site. Bump is hard" and "Leg is also swollen". Further information is expected. For reference purposes the case is linked to MCM-003723 (parent case/ same reporter).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site induration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2356148

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
CA
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
12.11.2021
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Discomfort Injection site erythema Injection site induration Injection site warmth Pyrexia

Symptomtext

Overall uncomfortable after the administration of VAXELIS; Warm to touch; 3.5 cm of redness induration and also warm to touch; Red spot at the VAXELIS injection site; Crying more than usual; Significant fever; This non-serious spontaneous safety report with agency reference #02151156 was received via partner on 20-APR-2022 and forwarded to agency on 21-APR-2022, from a Health Care Professional. The reporter did not assess the causal relationship between Vaxelis and the events 'overall uncomfortable after the administration of VAXELIS', 'warm to touch', '3.5 cm of redness induration and also warm to touch', 'red spot at the VAXELIS injection site', 'crying more than usual' and 'significant fever'. It was reported that the PCV 13 Vaccine was administered the same day (on the opposite thigh) as VAXELIS. It was considered as co-suspect given that the patient experienced 'crying more than usual', and 'significant fever'. Nonetheless, PCV 13 was concomitant for the other reported adverse events. Further information is expected. Significant follow-up was received via fax by agency on 12-MAY-2022, from a Health Care Professional. The reporter confirmed that the events were not serious. First dose of Vaxelis was administered on 12-NOV-2021. Second dose was administered on12-JAN-2022. End date and outcome of events were provided. The patient was treated with analgesic for pain, and cool or warm compresses. The reporter assessed the causal relationship between Vaxelis and the events 'overall uncomfortable after the administration of VAXELIS', 'warm to touch', '3.5 cm of redness induration and also warm to touch', 'red spot at the VAXELIS injection site', 'crying more than usual' and 'significant fever' as related. This case is maintained as non-serious. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2356147

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
WA
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
12.02.2022
Beginn
12.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Injection site erythema

Symptomtext

EXTRA DOSE ADMINISTERED; This case was retrieved during the monitoring on 11-Apr-2022 with the following reference number: 2189860-1. The original narrative from the sender is as follows: Two Hib containing vaccine were given to patient on the same day. Vaxelis (DTaP+Hib+IPV+HepB) and PedvaxHib were administered on 02/12/2022 by on-call MA. Vaxelis was given in left thigh and Hib in right thigh. Adverse events after prior vaccinations included redness on Right thigh injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2184373

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
MO
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
09.03.2022
Beginn
10.03.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cyanosis Pyrexia

Symptomtext

Lips turned blue; Temp at that time was 97, then with in ten minutes, temp was 103; This non-serious spontaneous case was received from a non-Health Care Professional via the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2184373-1. The original narrative from the sender is available and included in the source document: "Mom states that she thought he had a fever so she put him in a warm bath, his lips turned blue temp at that time was 97, then with in ten minutes his temp was 103". The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events: Lips turned blue, and Temp at that time was 97, then with in ten minutes, temp was 103. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Ear infection
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2184373

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
MO
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
09.03.2022
Beginn
10.03.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / OT
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Cyanosis Pyrexia

Symptomtext

Lips turned blue; Temp at that time was 97, then with in ten minutes, temp was 103; This non-serious spontaneous case was received from a non-Health Care Professional via the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2184373-1. The original narrative from the sender is available and included in the source document: "Mom states that she thought he had a fever so she put him in a warm bath, his lips turned blue temp at that time was 97, then with in ten minutes his temp was 103". The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events: Lips turned blue, and Temp at that time was 97, then with in ten minutes, temp was 103. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Ear infection
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2062020

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
NJ
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
08.11.2021
Beginn
09.11.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site mass Injection site swelling

Symptomtext

Red, swollen lump at injection site, 3cm in diameter; Injection site erythema; Red, swollen lump at injection site, 3cm in diameter; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2062020-1. The original narrative from the sender is as below: Red, swollen lump at injection site, 3cm in diameter. Redness and swelling lasted approximately 3 weeks. Lump palpable 2 months post-vaccine The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Injection site mass, Injection site erythema and Injection site swelling". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
VITAMIN D [VITAMIN D NOS]
Allergien
-
Vorherige Impfungen
-

VAERS 2062020

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
NJ
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
08.11.2021
Beginn
09.11.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site mass Injection site swelling

Symptomtext

Red, swollen lump at injection site, 3cm in diameter; Injection site erythema; Red, swollen lump at injection site, 3cm in diameter; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2062020-1. The original narrative from the sender is as below: Red, swollen lump at injection site, 3cm in diameter. Redness and swelling lasted approximately 3 weeks. Lump palpable 2 months post-vaccine The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "Injection site mass, Injection site erythema and Injection site swelling". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
VITAMIN D [VITAMIN D NOS]
Allergien
-
Vorherige Impfungen
-

VAERS 1536219

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

mild
Staat
LA
Alter
0,6
Geschlecht
M
Eingang
09.08.2021
Impfdatum
02.08.2021
Beginn
03.08.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Adenovirus infection Blood electrolytes Clostridium difficile infection Culture stool positive Decreased appetite Escherichia infection Full blood count Hypovolaemia Laboratory test Lethargy Polymerase chain reaction positive Pyrexia

Symptomtext

Patient developed fever, decreased appetite and lethargy the day after vaccination. Eventually, was admitted for IVVD and fever.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
3,0
Labordaten
Had numerous electrolyte, CBC, and other lab studies. Stool positive for C diff antigen and E. coli. Respiratory PCR positive for adenovirus before discharge.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2727930

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge :U7124AA

gering
Staat
AR
Alter
-
Geschlecht
F
Eingang
28.12.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Off label use Wrong product administered

Symptomtext

Patient is an 11-year-old patient who received VAXELIS but patient was supposed to received TDAP.; Patient is an 11-year-old patient who received VAXELIS but patient was supposed to received TDAP.; This non-serious spontaneous safety report with reference number 2023SA394450 (Inquiry number: 01883052) was received by a partner on 19-DEC-2023 and forwarded to UBC on 20-DEC-2023, from a HCP. This case was considered off-label use as Vaxelis was administered by mistake to an 11-year-old patient. Due to the nature of the event, the causality between the events; "Patient is an 11-year-old patient who received VAXELIS but patient was supposed to received TDAP." and Vaxelis was assessed as not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Off label use
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
HPV VACCINE; INFLUENZA VACCINE; MENINGOCOCCAL VACCINE CONJ
Allergien
-
Vorherige Impfungen
-

VAERS 2724888

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
MO
Alter
0,2
Geschlecht
M
Eingang
18.12.2023
Impfdatum
18.10.2023
Beginn
18.12.2023
Tage bis Beginn
61,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Medication error No adverse event Underdose

Symptomtext

NO ADVERSE EVENTS MEDICATION ERROR RSV-Nirsevimab(Beyfortus) is based on weight Administer only half dose of the vaccine, 0.5 ml instead of 1.0 ml. DOS - Patient weignt was 11 lbs 8 oz = to 5.22 kgs. Patient's correct dosage should of be 1.0 ml for > 5 kgs. Will give additional dose of Beyfortus 0.5 ml at next OV (12/19/23) per RA and CDC guidelines

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
BEYFORTUS
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2724886

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
AR
Alter
0,2
Geschlecht
M
Eingang
18.12.2023
Impfdatum
18.10.2023
Beginn
18.12.2023
Tage bis Beginn
61,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Underdose

Symptomtext

NO ADVERSE EVENTS MEDICATION ERROR RSV-Nirsevimab(Beyfortus) is based on weight Administer only half dose of the vaccine, 0.5 ml instead of 1.0 ml. DOS - Patient weignt was 11 lbs 4 oz = to 5.1 kgs. Patient's correct dosage should of be 1.0 ml for > 5 kgs. Will give additional dose of Beyfortus 0.5 ml at next OV (12/19/23) per state and CDC guidelines

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2688169

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
VA
Alter
4,0
Geschlecht
M
Eingang
28.09.2023
Impfdatum
30.08.2021
Beginn
-
Tage bis Beginn
-
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Caller, calling on behalf of a physician, stated that a patient received Vaxelis at 5 years of age and that the dosing intervals were correct; Male patient born on 16 July 2017, who had not previously received any doses of the vaccines contained in Vaxelis, was administered Vaxelis on a catch-up schedule for three doses on the following dates: 30 Aug 2021, 10 Nov 2021, and 25 Aug 2022.; This non-serious spontaneous safety report, with case Number 2023SA202003 (Inquiry Number 01674630), was received by partner, on 30JUN2023 and forwarded on 03JUL2023 from a healthcare professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events. "Caller, calling on behalf of a physician, stated that a patient received Vaxelis at 5 years of age and that the dosing intervals were correct and, male patient born on 16 July 2017, who had not previously received any doses of the vaccines contained in Vaxelis, was administered Vaxelis on a catch-up schedule for three doses on the following dates: 30 Aug 2021, 10 Nov 2021, and 25 Aug 2022." Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2490934

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
MI
Alter
-
Geschlecht
F
Eingang
04.04.2023
Impfdatum
19.10.2022
Beginn
19.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Gave quadracel vaccination out of age range; Notified mother of incorrect vaccine product used and vaxelis product given in same limb; Gave quadracel vaccination out of age range; Notified mother of incorrect vaccine product used and vaxelis product given in same limb; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JAN-2023 with the following VAERS Primary ID 2490934-1. The original narrative from the sender is the following: Gave quadracel vaccination out of age range; Notified mother of incorrect vaccine product used and vaxelis product given in same limb. The reporter did not provide an assessment of causal relationship between Vaxelis and the event "Wrong Product Administered," and "Overdose." No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544247

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
IN
Alter
0,4
Geschlecht
F
Eingang
28.12.2022
Impfdatum
22.11.2022
Beginn
09.11.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Patient was administered VAXELIS on 22NOV2022 and the excursion occurred on 09NOV2022/ Temperature it reached was 10.1C; This spontaneous safety report, with reference number 2022SA509263 (Inquiry Number 01407148) was received by the partner on 14-DEC-2022 and forwarded to Agency on 16-DEC-2022, from a health professional. Due to the nature of the event, the causality between the event "Patient was administered VAXELIS on 22NOV2022 and the excursion occurred on 09NOV2022/ Temperature it reached was 10.1C" and Vaxelis was not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
PNEUMOCOCCAL VACCINE 13V
Allergien
-
Vorherige Impfungen
-

VAERS 2544188

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
AZ
Alter
-
Geschlecht
F
Eingang
28.12.2022
Impfdatum
31.08.2022
Beginn
31.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Depressed level of consciousness

Symptomtext

After give immunizations instructed Mom to wait for 15 minutes. Baby was asleep, tired to arouse baby with sternal rub- baby still sleeping, checked pupils with bright light, baby still sleeping.; Cry and was easily aroused; This case was retrieve during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2425360-1. The original narrative from the sender is the following: After giving immunizations instructed Mom to wait with both children for 15 mins in our vaccination room and when returning to give mother the visit summary at 11:40am , baby was sitting in infant seat sound asleep, tired to arouse baby with sternal rub- baby still sleeping, checked pupils with bright light, baby still sleeping. Mother reported that baby's nap time is usually around this time of day and she had been up since 6 am and last feeding was at 10:30am . Asked RN to please hold baby and stay with mom , retrieved our NP and our volunteer to please help assess baby in vaccination room. Applied child size bp cuff on left thigh to obtain bp reading and then baby began to cry and was easily aroused. Baby was then placed in mother's arms and baby was smiling and awake. Informed with help from translating RN that should mother see any changes in baby's respirations or behavior to please go to er or call emergency services for evaluation . Let her know that usually in the first 15 mins post vaccination that is when a reaction is likely to occur. Baby Awake and alert and responding to her mother. Discharged in stable condition with mom. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "After give immunizations instructed Mom to wait for 15 minutes. Baby was asleep, tired to arouse baby with sternal rub- baby still sleeping, checked pupils with bright light, baby still sleeping." and "cry and was easily aroused". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Crying
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2544181

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
MO
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
22.08.2022
Beginn
22.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

provider ordered DTAP-IPV but DTAP-IPV-Hib-HepB(Vaxelis) was given; Vaccine administered to a 5year old child; This case was retrieve during the Reporting System monitoring on 12-OCT-2022 with the following Primary ID 2443227-1. The original narrative from the sender is the following: Provider ordered DTAP-IPV, but DTAP-IPV-Hib-HepB (Vaxelis)was given. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported event "Wrong product administered". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464154

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
29.09.2022
Impfdatum
23.08.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Nurse calling for TE evaluation states 3 doses of VAXELIS in PFS involved in the excursion have been administered to patients; This non-serious spontaneous safety report reference #02238017/ interaction #02237963 was received by a partner on 01-SEP-2022 from a Nurse, and forwarded on 02-SEP-2022. Due to the nature of the event, the causality between Vaxelis and the reported event of "Nurse calling for TE evaluation states 3 doses of VAXELIS involved in the excursion have been administered to patients" was not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464152

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
29.09.2022
Impfdatum
-
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Nurse calling for TE evaluation on refrigerated products state 3 doses of Vaxelis in PFS involved in this excursion have been administered to patients; This spontaneous safety report, with interaction number 02237963, was received by the partner on 01-SEP-2022 and forwarded to Agency on 02-SEP-2022, from a health professional. Due to the nature of the event, the causality between the event "Nurse calling for TE evaluation on refrigerated products state 3 doses of Vaxelis in PFS involved in this excursion have been administered to patients; VAXELIS :Temperature/Time frame (48.2F) for 6 hours 40 minutes", and Vaxelis was not applicable. Further information is expected. For reference purposes cases is linked to: MCM-003974 and MCM-003975.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464129

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
-
Geschlecht
M
Eingang
29.09.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Vaccination error

Symptomtext

Thought I needed to give the patient vaxelis. Misunderstood the NP orders.; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2290529-1. The original narrative from the sender is as below: Thought I needed to give the patient vaxelis. Misunderstood the NP orders. Child didn't have no reaction or distress after the vaccine was administered. Pt mother was aware of the vaccine given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464126

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error No adverse event Wrong product administered

Symptomtext

While checking inventory that Pediarix was documented as given, but vaxelis was actually adminstered; Received 2 doses of Hib in error; No adverse reaction was reported; This non-serious case was received during the Reporting System monitoring on 12-JUL-2022 with the following Primary ID 2312795-1. The original narrative from the sender is the following: No adverse reaction was reported. It was discovered on 6/1/2022 while checking inventory that Pediarix was documented as given, but Vaxelis was actually administered. Baby received 2 doses of Hib in error. Mother/guardian of child was telephone on 6/1/2022, at number provided in patient's record, but message ""not accepting calls"" was received. Her voice mail box was full, so no message was left.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464125

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

While checking inventory that Pediarix was documented as given, but vaxelis was actually adminstered; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2312794-1. The original narrative from the sender is the following: No adverse reaction was reported. It was discovered on 6/1/2022 while checking inventory that Pediarix was documented as given, but Vaxelis was actually administered. Baby received 2 doses of Hib in error. Mother/guardian of child was telephoned on 6/1/2022, at number provided in patient's record, but message "not accepting calls" was received. Her voice mail box was full, so no message was left.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464123

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124aa

gering
Staat
DC
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Circumstance or information capable of leading to medication error No adverse event Wrong product administered

Symptomtext

Vaccine given in error; No adverse reaction to vaccine; This non-serious case was received during the Reporting System monitoring on 12-JUL-2022 with the following Primary ID 2307076-1. The original narrative from the sender is the following: Vaccine given in error. Order was for Varicella (Varivax) which was misread and Dtap IPV HIb HepB (Vaxelis) administered. Pt had no adverse reaction to vaccine and will receive correct vaccine during 15 month well child check. The reporter did not provide an assessment of causal relationship between Vaxelis and the reported events "Vaccine given in error". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464089

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
29.09.2022
Impfdatum
-
Beginn
11.07.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

A vaccine that experienced a supported temp excursion was administered to patients; This non-serious spontaneous safety report was received with reference numbers 02202408 / 02202359 on 11-JUL-2022 and forwarded on 12-JUL-2022 from another health care professional. The causal relationship between Vaxelis and the reported event of "Vaccine that experienced a supported temp excursion was administered to patients; Temperature 35.1F" was assessed as not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2312794

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Extra dose administered; Wrong product administered; No adverse event; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System(VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2312796-1 . The original narrative from the sender is as below: No adverse event was reported. It was discovered on 6/1/2022 while checking inventory that pediarix was documented as given but vaxelis was actually administered. Baby received 2 doses of Hib in error. Mother/guardian if child was telephoned on 6/1/2022, at number provided in patients record, but message "not accepting calls" was received. her voice mail box was full, so no message was left.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2231142

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
NY
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event Product administration error Product preparation error

Symptomtext

2 month baby received rotarix vaccine by IM instead of orally; 2 month baby received rotarix vaccine by IM instead of orally. Rotarix reconstituted using sterile water and administered IM; 2 month baby received rotarix vaccine by IM instead of orally. Rotarix reconstituted using sterile water and administered IM; No adverse event noted for about 2 hours and the next two days; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System(VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2231142-1. The original narrative from the sender is as below: Vaccine administartion error** 2 month baby received rotarix vaccine by IM instaed of orally. Rotarix reconstituted using sterile water and administered IM. No any adverse reactions noted for about 2 hrs and the next two days. We haven't heard anything from parent that baby developed any adverse reaction after that up until now as of 4/13/2022. Parent brought the baby to ED that afternoon not because of adverse reaction but because they wanted to make sure if everything was okay and received counselling regarding vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2220967

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TX
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
14.03.2022
Beginn
21.03.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Haematochezia

Symptomtext

Product use in unapproved population; Blood in stools for a week.; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2220967-1. The original narrative from the sender is as below: Blood in stools for a week. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Haematochezia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Atrioventricular canal (Repair of atrioventricular canal at birth); Chromosomal anomalies (8p23. 1 duplication); Feeding tube user (for feeding difficulty)
Vorgeschichte
Medical History/Concurrent Conditions: Coarctation of aorta (Coartctation of aorta at birth)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2220967

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TX
Alter
-
Geschlecht
F
Eingang
29.09.2022
Impfdatum
14.03.2022
Beginn
21.03.2022
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Haematochezia

Symptomtext

Product use in unapproved population; Blood in stools for a week.; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2220967-1. The original narrative from the sender is as below: Blood in stools for a week. No further information expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Haematochezia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Atrioventricular canal (Repair of atrioventricular canal at birth); Chromosomal anomalies (8p23. 1 duplication); Feeding tube user (for feeding difficulty)
Vorgeschichte
Medical History/Concurrent Conditions: Coarctation of aorta (Coartctation of aorta at birth)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2443227

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
MO
Alter
5,0
Geschlecht
M
Eingang
13.09.2022
Impfdatum
22.08.2022
Beginn
22.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Provider ordered DTAP-IPV, but DTAP-IPV-Hib-HepB (Vaxelis) was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2425360

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
AZ
Alter
0,6
Geschlecht
F
Eingang
31.08.2022
Impfdatum
31.08.2022
Beginn
31.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Crying Unresponsive to stimuli

Symptomtext

After giving immunizations instructed Mom to wait with both children for 15 mins in our vaccination room and when returning to give mother the visit summary at 11:40am , baby was sitting in infant seat sound asleep, tired to arouse baby with sternal rub- baby still sleeping, checked pupils with bright light, baby still sleeping. Mother reported that baby's nap time is usually around this time of day and she had been up since 6 am and last feeding was at 10:30am . Asked RN to please hold baby and stay with mom , retrieved our NP and our volunteer to please help assess baby in vaccination room. Applied child size bp cuff on left thigh to obtain bp reading and then baby began to cry and was easily aroused. Baby was then placed in mother's arms and baby was smiling and awake. Informed with help from translating RN that should mother see any changes in baby's respirations or behavior to please go to er or call 911 for evaluation . Let her know that usually in the first 15 mins post vaccination that is when a reaction is likely to occur. Baby Awake and alert and responding to her mother. Discharged in stable condition with mom.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Crying
Hospital-Tage
-
Labordaten
none ordered Baby responded awake, alert and responsive to noxious stimuli, bp cuff , bright lights pupils PERRLA.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
nnkda
Vorherige Impfungen
-

VAERS 2356149

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
OR
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

VAXELIS was administered to a patient after his 5th birthday; This non-serious spontaneous safety Report with reference number 2022SA161948, was received by Sanofi, on 03-May-2022 and forwarded on 05-May-2022 from a HCP. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported off-label event, "VAXELIS was administered to a patient after his 5th birthday". No further information is expected because HCP does not want to be contacted

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2356136

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TX
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

EXTRA DOSE ADMINISTERED; NO ADVERSE EVENT; This case was retrieved during the ICSR monitoring on Vaccine Adverse Event Reporting System (VAERS) on 11-Apr-2022 with the following reference number: 2028440-1. The original narrative from the sender is: No adverse reaction, gave two doses of Hep B at time of vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Otitis media; Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2356126

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
NM
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
-
Beginn
06.01.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products No adverse event

Symptomtext

9 month old was given VAXELIS at 2 months old and 4 months old, and then given PEDIARIX at 6 months old.; This non-serious spontaneous safety report with reference #02144115 was received by a partner on 08-APR-2022 and forwarded on 11-APR-2022 from a health care professional. The causal relationship between Vaxelis and the reported event "9 month old was given VAXELIS at 2 months old and 4 months old, and then given PEDIARIX at 6 months old" is assessed as not applicable due to the nature of the event. Further information is expected. FOLLOW-UP information was received by a partner on 18-APR-2022 and forwarded on 19-APR-2022 from a health care professional. The case is maintained as non-serious. The causal relationship between Vaxelis and the reported event "9 month old was given VAXELIS at 2 months old and 4 months old, and then given PEDIARIX at 6 months old" remains not applicable due to the nature of the event. Further information is expected. SIGNIFICANT FOLLOW-UP information was received on 18-MAY-2022 from a health care professional. The case is maintained as non-serious. It was reported that no adverse reactions occurred due to the interchange of vaccines (event onset date 06-JAN-2022). Patient's concomitant vaccinations at 6 months appointment were Prevnar, RotaTeq, and Influenza along with Pediarix. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2178992

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
10.02.2022
Beginn
05.02.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; The temperature excursion had occurred when both vaccines were exposed to 0.8 degrees Celsius for 35 minutes on 05-FEB-2022; This non-serious case was received from a Health Care Professional via the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2178992 and databased on 13-APR-2022. The original narrative from the sender is the following: "No additional AE reported; Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concomitant medications, concurrent conditions, medical history and drug reactions/allergies were not reported. On 10 FEB-2022, the patient was vaccinated with both improperly stored Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally (lot # 1741817, expiration date: 30-JUL-2022, strength and dose were unknown) and diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid (V419) (lot # U7124AA, expiration date: 13-JUL-2024, strength, dose and route were unknown) for prophylaxis (product storage error). The temperature excursion had occurred when both vaccines were exposed to 0.8 degrees Celsius for 35 minutes on 05-FEB-2022 as confirmed by reporter. There was no previous excursion. No additional adverse event was reported." Due to the nature of the reported event, the causality between Vaxelis and the events "Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS, and The temperature excursion had occurred when both vaccines were exposed to 0.8 degrees Celsius for 35 minutes on 05-FEB-2022" was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2178210

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

NO ADVERSE EVENT; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; This case was retrieved during the monitoring on the Vaccine Adverse Event Reporting System (VAERS) on 11-Apr-2022 with the following reference number: 2178210-1. The original narrative from the sender is as follows: Dose of Vaxelis given to an 11 year patient (out of recommended age range). This was not noted until approx 6 weeks later. Pt had no adverse events or symptoms reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2178210

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
03.07.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

NO ADVERSE EVENT; PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE; This case was retrieved during the monitoring on the Vaccine Adverse Event Reporting System (VAERS) on 11-Apr-2022 with the following reference number: 2178210-1. The original narrative from the sender is as follows: Dose of Vaxelis given to an 11 year patient (out of recommended age range). This was not noted until approx 6 weeks later. Pt had no adverse events or symptoms reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2011217

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
UT
Alter
-
Geschlecht
M
Eingang
03.07.2022
Impfdatum
04.01.2022
Beginn
05.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Haematochezia Occult blood positive

Symptomtext

HAEMATOCHEZIA; OCCULT BLOOD POSITIVE; This non-serious spontaneous case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 11-APR-2022 with the following VAERS Primary ID 2011217-1. The original narrative from the sender is as below: Developed hematochezia 24 hours after first dose of Rotavirus.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Haematochezia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
Medical History/Concurrent Conditions: Heart murmur; Pulmonary valve stenosis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2312795

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
0,6
Geschlecht
F
Eingang
07.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Wrong product administered

Symptomtext

No adverse reaction was reported. It was discovered on 6/1/2022 while checking inventory that Pediarix was documented as given, but Vaxelis was actually administered. Baby received 2 doses of Hib in error. Mother/guardian of child was telephone on 6/1/2022, at number provided in patient's record, but message "not accepting calls" was received. Her voice mail box was full, so no message was left.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2307076

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124aa

gering
Staat
DC
Alter
1,2
Geschlecht
F
Eingang
02.06.2022
Impfdatum
20.05.2022
Beginn
20.05.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Vaccine given in error. Order was for Varicella (Varivax) which was misread and Dtap IPV HIb HepB (Vaxelis) administered. Pt had no adveres reaction to vaccine and will receive correct vaccine during 15 mon well child check.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
none
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2290529

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
4,0
Geschlecht
M
Eingang
23.05.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Thought I needed to give the patient vaxelis. Misunderstood the NP orders. Child didn't have no reaction or distress after the vaccine was administered. Pt mother was aware of the vaccine given

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2210853

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.04.2022
Impfdatum
25.02.2022
Beginn
05.02.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Temperature: 0.8?C (Temperature Excursion had occurred on 02/05/2022. On 02/25/2022, patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS.; This non-serious spontaneous safety report, with reference number 02125903 (and interaction # 02125857), was received by the partner on 10-MAR-2022 and forwarded to Agency on 15-MAR-2022, from a Nurse. Due to the nature of the event, the causality between the reported event "Temperature: 0.8?C (Temperature Excursion had occurred on 02/05/2022. On 02/25/2022, patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS." and Vaxelis was assessed as not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210852

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.04.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; Improperly Stored; This non-serious spontaneous safety report with reference number 02125902 was received by a partner on 10-MAR-2022 and forwarded to Agency on 15-MAR-2022 from a health care professional. The causal relationship between Vaxelis and the reported event Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; Improperly Stored is assessed as not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210851

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.04.2022
Impfdatum
20.02.2022
Beginn
20.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Patient was administered both improperly stored Vaxelis and Rotateq; This non-serious spontaneous safety report with reference number 02125894 was received by the partner on 10-Mar-2022 and forwarded to Agency on 15-Mar-2022 from another health care professional. The causal relationship between Vaxelis and the reported event is not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210850

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
01.04.2022
Impfdatum
10.02.2022
Beginn
05.02.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; This non-serious spontaneous safety report with reference number 02125895 was received by a partner on 10-MAR-2022 and forwarded to Agency on 14-MAR-2022 from a health care professional. The causal relationship between Vaxelis and the reported event of "On 10-Feb-2022, patient was administered both improperly stored ROTATEQ, and improperly stored VAXELIS (product temperature excursion happened on 05-Feb-2022)" is assessed as not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210849

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TX
Alter
0,2
Geschlecht
U
Eingang
01.04.2022
Impfdatum
18.10.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incomplete course of vaccination

Symptomtext

The patient did not receive his/her 4 month or 6 month dose of VAXELIS.; This non-serious spontaneous safety report with reference number 02126618 was received by a partner on 11-MAR-2022 and forwarded to Agency on 14-MAR-2022 from a health care professional. The causal relationship between Vaxelis and the reported event 'The patient did not receive his/her 4 month or 6 month dose of VAXELIS' was assessed as not applicable due to the nature of the event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incomplete course of vaccination
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210847

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
CO
Alter
0,3
Geschlecht
M
Eingang
01.04.2022
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration Product administered to patient of inappropriate age

Symptomtext

Received his first dose of VAXELIS at 4 months/patient received Hepatitis B at birth.; The baby missed his vaccinations at TWO months old; This non-serious spontaneous safety report with reference number #2022SA024585 was received by a partner on 25-JAN-2022 and forwarded to regulatory authority on 27-JAN-2022 from a health care professional. The causal relationship between Vaxelis and the reported events "received his first dose of VAXELIS at 4 months/patient received Hepatitis B at birth" and "the baby missed his vaccinations at two months old" was assessed as not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
PNEUMOCOCCAL CONJUGATE VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2210846

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
LA
Alter
1,7
Geschlecht
F
Eingang
01.04.2022
Impfdatum
19.10.2021
Beginn
19.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

PRODUCT ADMINISTERED AT INAPPROPRIATE SITE; PRODUCT STORAGE ERROR; This case was retrieved during the VAERS-ICSR monitoring in FDA on 12-JAN-2022 with the following reference number: 1827116-1. The original narrative from the sender is as below: "No additional AE was reported; temperature excursion for VARIVAX; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medication was not provided. On 19-OCT-2021, the patient was vaccinated with improper stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # T024287,expiration date 15-JUL-2022, 0.5 milliliter, route and strength were not provided) for prophylaxis (product storage error). The vaccine administered experienced temperature excursion of 8 Degree Celsius for 1 hour 47 minutes. There was no previous temperature excursion. No additional adverse event was reported. Follow up information has been received from vaccine coordinator on 26-OCT-2021. Information has been received regarding a 20-month-old female patient who weights 6lb 12Oz at the time of birth. She had 2 sisters. On 19-OCT-2021, she was vaccinated with an improperly stored first dose of varicella virus vaccine live (oka/merck) (VARIVAX) administered subcutaneously (SQ) through right arm; with the first dose of diphtheria vaccine toxoid (+) hepatitis B vaccine rhbsag (yeast) (+) hib vaccine conj (menigococcal protein) (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (VAXELIS) (dosage regimen not provided), lot# U7124AA, expiration date 13-JUL-2024 administered intramuscularly (IM) through left thigh; with the first dose of hepatitis A vaccine (dosage regimen not provided), lot# 2JD3Y, expiration date 04-DEC-2022, IM through left thigh; and with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live recombinant human albumin (rHA) (M-M-R II) (dosage regimen not provided), lot# S039316, expiration date 04-DEC-2021, SQ through left arm. All vaccines were storage in clinical practice administered as prophylaxis. On that day, second dose of pneumococcal vaccine conj 13v (CRM197) (PREVENAR 13) (dosage regimen was not provided) lot# DL2971, expiration date 30-NOV-2022, IM through right thigh for prophylaxis. It was reported that the operator was trained, and the vaccine was used according to the instruction's leaflet; however, the vaccine was not available for return because was used. On that day, the clinic lost power and the vaccine was administered to the patient before being cleared by manufacturer for use. On 20-OCT-2021, the manufacturer was contacted and were cleared all affected vaccines for use. The patient involved had not reported any adverse reactions to immunization. All staff clinic was aware to have vaccines cleared by manufacturer after a temperature excursion. The temperature excursion occurred as a result of a reading from the digital data logger." Notes: Based on the available information, the events were not related to Vaxelis but to Varivax vaccine. Vaxelis should have been considered a concomitant, however the case was retrieved from VAERS and information was kept as reported in the form.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210844

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
WA
Alter
-
Geschlecht
M
Eingang
01.04.2022
Impfdatum
-
Beginn
20.10.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Off label use Product use issue Wrong product administered

Symptomtext

Wrong product administered; Administered Vaxelis, Hep B, and PCV; Product use in unapproved population; No adverse event; This case was retrieved on 12-JAN-2022 with the following reference number: 1801803. The original narrative from the sender is as below: Patient came in for a well child check today and the provider ordered the administration of Vaxelis, PCV-13, and Rotavirus vaccine. While I was taking these out of the fridge, I got distracted and pulled out Hep B by mistake instead of rotavirus. I administered Vaxelis, Hep B, and PCV. Within one minute of administration, I realized that I gave Hep B by mistake and forgot to administer the rotavirus vaccine. I immediately informed the provider, and she spoke with the patient's mother. Patient did not experience any symptoms or signs while in the office, and the provider advised mother to monitor for any concerning signs or symptoms. The case was considered off-label use, since product was administer in unapproved population (patient 1 month old).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Off label use
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2210842

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KY
Alter
0,3
Geschlecht
M
Eingang
01.04.2022
Impfdatum
09.12.2021
Beginn
09.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

The caller said that 1 patient received Rotateq and Vaxelis after a temperature excursion; This non-serious spontaneous safety report with reference number 02082971 and 02082963 was received by a partner on 04-JAN-2022 and forwarded to regulatory authority on 07-JAN-2022 from a health care professional. The causal relationship between Vaxelis and the reported event of a patient received Rotateq and Vaxelis after a temperature excursion was assessed as not applicable due to the nature of the event. Further information is expected. SIGNIFICANT follow-up information was received by Fax from a HCP on 24-Jan-2021. The case is maintained as non-serious. The reporter confirmed that the patient did not experience any Adverse Event following the administration of Vaxelis. The temperature excursion occurred because a vaccine box did not allow the refrigerator to be closed completely. The vaccine box was moved and the door was closed completely. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1840096

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
UT
Alter
-
Geschlecht
M
Eingang
01.04.2022
Impfdatum
26.10.2021
Beginn
27.10.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site erythema Vaccination site warmth

Symptomtext

Vaccination site warmth; Vaccination site erythema; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-Jan-2022 with the following VAERS Primary ID 1840096. The original narrative from the sender is the following: Mild erythema and warmth surrounding vaccine site of bilateral thighs. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events "mild erythema and warmth surrounding the vaccine site of both thighs". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Candidiasis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208806

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
CA
Alter
11,0
Geschlecht
U
Eingang
31.03.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

11 year old receiving Vaxelis; This spontaneous safety report was received by the partner on 14-Mar-2022 and forwarded to Agency on 15-Mar-2022 from an other health care professional. Due to the nature of the event, the causality between the event "11 year old receiving Vaxelis" and the product is not applicable. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208797

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TN
Alter
0,3
Geschlecht
M
Eingang
31.03.2022
Impfdatum
09.09.2021
Beginn
09.11.2021
Tage bis Beginn
61,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products No adverse event

Symptomtext

Received dose of Pediarix at 2 months and Vaxelis at 4 months; This non-serious spontaneous safety report case #02087821 and Interaction #02087770 was received from a Medical Assistant by the partner on 10-Jan-2022 and forwarded on 11-Jan-2022. Due to the nature of the event, the causality between Vaxelis and the reported event: "the patient received a dose of Pediarix at 2 months followed by a dose of Vaxelis at 4 months" was not applicable. Further information is expected. FOLLOW-UP INFORMATION case #02087821 was received from a Medical Assistant by the partner on 28-Jan-2022 and forwarded on 31-Jan-2022. The case is maintained as non-serious. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient and that the Department of Health recommended Vaxelis at the 6 month visit. Due to the nature of the event, the causality between Vaxelis and the reported event: "the patient received a dose of Pediarix at 2 months followed by a dose of Vaxelis at 4 months" remains not applicable. Further information is not expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
POLYVISOL [ASCORBIC ACID;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL
Allergien
-
Vorherige Impfungen
-

VAERS 2208796

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
WA
Alter
0,3
Geschlecht
F
Eingang
31.03.2022
Impfdatum
14.12.2021
Beginn
02.11.2021
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product storage error

Symptomtext

Patient received V AXELIS after it experienced a temperature excursion of 8.5?C for 30 min.; This non-serious spontaneous safety report with Agency reference# 02080038 was received by a partner on 22-Dec-2021 from a Health Care Professional, and forwarded to Agency on 23-Dec-2021. Due to the nature of the event, the causality between Vaxelis and the reported event of Temperature excursion' was not applicable. For reference purposes this case is linked to MCM-002954, MCM-002953, MCM-002957 due to same reporter. Further information is expected. FOLLOW-UP INFORMATION was received by Fax from a HCP on 27-Jan-2022. On 28-Jan-2022 additional information was received by the partner from the same HCP and forwarded to Agency on 31-Jan-2022. The case is maintained as non-serious. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between Vaxelis and the reported event of 'Patient received Vaxelis after temperature excursion of 8.5 degrees for 30 min' remained not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208795

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
WA
Alter
0,3
Geschlecht
M
Eingang
31.03.2022
Impfdatum
21.12.2021
Beginn
02.11.2021
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product storage error

Symptomtext

Patient received Vaxelis after it received temperature excursion of 8.5 degrees for 30 mins; This non-serious spontaneous safety report with Agency reference# 02080037 was received by a partner on 22-Dec-2021 from a Health Care Professional, and forwarded to Agency on 23-Dec-2021. Due to the nature of the event, the causality between Vaxelis and the reported event of 'Temperature excursion' was not applicable. For reference purposes this case is linked to MCM-002953, MCM-002956, MCM-002957 due to same reporter. Further information is expected. FOLLOW-UP INFORMATION was received by Fax from a HCP on 27-Jan-2022. On 28-Jan-2022 additional information was received by the partner from the same HCP and forwarded to Agency on 31-Jan-2022. The case is maintained as non-serious. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between Vaxelis and the reported event of 'Patient received Vaxelis after temperature excursion of 8.5 degrees for 30 min' remained not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2208794

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
WA
Alter
0,2
Geschlecht
F
Eingang
31.03.2022
Impfdatum
11.11.2021
Beginn
02.11.2021
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product storage error

Symptomtext

The patient received Vaxelis after it experienced a temperature excursion 8.5 degree for 30 minutes; This non-serious spontaneous safety report was received by regulatory agency reference# 02080012 on 22-DEC-2021 and forwarded on 23-DEC-2021 from a Health Care Professional. Due to the nature of the event, the causality between Vaxelis and the reported event of 'Temperature excursion' was not applicable. For reference purposes this case is linked to MCM-002954, MCM-002956, MCM-002957 due to same reporter. Further information is expected. FOLLOW-UP INFORMATION was received by Fax from a HCP on 27-Jan-2022. On 28-Jan-2022 additional information was received by the partner from the same HCP and forwarded on 31-Jan-2022. The case is maintained as non-serious. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient. Due to the nature of the event, the causality between the event "Patient received Vaxelis after temperature excursion of 8.5 degrees for 30 min" and Vaxelis remains not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1940251

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge u7124aa

gering
Staat
WA
Alter
-
Geschlecht
F
Eingang
31.03.2022
Impfdatum
10.12.2021
Beginn
10.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient given additional HIB; This case was retrieved during Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-Jan-2022 with the following VAERS Primary ID 1940251. The original narrative from the sender is the following: Patient was given additional HIB as medical assistant unaware that HIB was also present in Vaxelis. The causal relationship between Vaxelis and the event "patient given additional HIB" was assessed as not applicable due to the nature of the event. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
VITAMIN D 3
Allergien
-
Vorherige Impfungen
-

VAERS 1745229

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
F
Eingang
31.03.2022
Impfdatum
29.09.2021
Beginn
29.09.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient received ProQuad and Varicella at this visit; This case was retrieved during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JAN-2022 with the following reference number: 1745229-1. The original narrative from the sender is as following: "Patient received ProQuad and Varicella at this visit." The causal relationship between Vaxelis and the event "Patient received ProQuad and Varicella at this visit" was assessed as not applicable due to the nature of the event. Of note, the event do not concern Vaxelis, but rather ProQuad and Varicella vaccines. Vaxelis should had been considered as concomitant. However, the case was databased to mirror what was reported in VAERS. No further information is expected

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2189860

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
WA
Alter
0,3
Geschlecht
F
Eingang
21.03.2022
Impfdatum
12.02.2022
Beginn
12.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Two Hib containing vaccine were given to patient on the same day. Vaxelis (DTaP+Hib+IPV+HepB) and PedvaxHib were administered on 02/12/2022 by on-call MA. Vaxelis was given in left thigh and Hib in right thigh.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
Redness on Right thigh injection site

VAERS 2183501

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
17.03.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No addittional adverse events reported; Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported. On 05-FEB-2022, both rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot #1741817, expiration date 30-JUL-2022) and diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) (lot #U7124AA, expiration date 13-JUL-2024) had occurred a temperature excursion in 0.8 degree Celsius for 35 minutes. And on 09-FEB-2022, the patient was vaccinated with both improperly stored vaccines (strength, dose and route of administration were not provided) for prophylaxis (product storage error). There was no previous temperature excursion. No additional adverse event (AE) reported. This is one of multiple cases received from the same reporter.; Sender's Comments: USA-009507513-2203USA003814: USA-009507513-2203USA003938: USA-009507513-2203USA003853: USA-009507513-2203USA003841: USA-009507513-2203USA003951: USA-009507513-2203USA003955:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2178991

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
15.03.2022
Impfdatum
25.02.2022
Beginn
25.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Patient was administered both improperly stored ROTATEQ and improperly stored VAXELIS; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported. On 05-FEB-2022, both rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot #1741817, expiration date 30-JUL-2022) and diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) (lot #U7124AA, expiration date 13-JUL-2024) had occurred a temperature excursion in 0.8 degree Celsius for 35 minutes. And on 25-FEB-2022, the patient was vaccinated with both improperly stored vaccines (strength, dose and route of administration were not provided) for prophylaxis (product storage error). There was no previous temperature excursion. No additional adverse event (AE) reported. This is one of multiple cases received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2178989

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7124AA

gering
Staat
KS
Alter
-
Geschlecht
U
Eingang
15.03.2022
Impfdatum
20.02.2022
Beginn
20.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE reported; Patient was administered both improperly stored ROTATEQ, improperly stored VAXELIS; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 20-FEB-2022, the patient was vaccinated with an improperly stored of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis (lot # 1741817, has been verified to be a valid lot number rotavirus vaccine, live, oral, pentavalent, expiration date reported and establish as 30-JUL-2022) (strength, dose, route of administration and anatomical location were not provided) and diphtheria vaccine toxoid (+) hepatitis b vaccine rhbsag (yeast) (+) hib vaccine conj (menigococcal protein) (+) pertussis vaccine acellular 5-component (+) polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (VAXELIS) (lot # U7124AA, expiration date reported as 13-JUL-2024) (strength, dose, route of administration and anatomical location were not provided). The temperature of storage and time frame of the excursion were 0.8? Celsius (C) for 35 minutes respectively. If a digital data logger was involved was not reported. The vaccines experienced a previous temperature excursion. No adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2028440

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TX
Alter
1,7
Geschlecht
F
Eingang
12.01.2022
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

no adverse reaction, gave two doses of Hep B at time of vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
otitis media
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2017317

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge u7124AA

gering
Staat
KY
Alter
-
Geschlecht
U
Eingang
08.01.2022
Impfdatum
12.09.2021
Beginn
12.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no adverse event; patient received ROTATEQ and VAXELIS after a temperature excursion; This spontaneous report as received from a Licensed Practical Nurse to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant therapies were not provided. On 12-SEP-2021, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # T040207, expiration date of 18-JUL-2022, orally and diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid (VAXELIS) lot# u7124AA expiration date of 13-JUL-2024, after a temperature excursion (product storage error) for prophylaxis. The temperature excursion was 49F and lasted 1 hour 24 minutes. There was no previous temperature excursion. No adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2000140

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7124AA

gering
Staat
TX
Alter
0,2
Geschlecht
M
Eingang
03.01.2022
Impfdatum
20.12.2021
Beginn
20.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event Wrong product administered

Symptomtext

no adverse symptoms were reported; Wrong Drug Administered/inadvertently administered VAXELIS; extra dose simultaneously of Hepatitis B; HepB was not deleted from orders and was administered along with Vaxelis; This spontaneous report as received from a nurse practitioner and medical assistant via company representative concerning a 2-month-old patient, gender unspecified with no illness at the time of vaccination. There was no information about the patient's medical history or concurrent conditions. Concomitant medication include: First dose of : rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and pneumococcal vaccine conj 13v (crm197)(PREVENAR 13),administered on the same date. Medical assistant reported that the patient was inadvertently vaccinated with a first dose of diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS), lot number: U7124AA, expiration date: 13-JUL-2024, intramuscularly, in the right deltoid (dose was not reported)for prophylaxis in combination with a second dose of hepatitis b vaccine rhbsag (yeast)(ENGERIX), in the left deltoid (lot number: FB9RH, expiration date: 21-JAN-2024) (dose was not reported) for prophylaxis instead of the originally reported Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) (dose, route of administration, lot number and expiration date were not reported), on 20-DEC-2021 in separately locations. No additional information provided. No additional adverse events reported. No product quality complaints reported. No further details provided. No digital data logger was reporter. The medical assistant mentioned that while ordering new vaccines for the well visit , and the Hepatitis B was not deleted from the orders (product prescribing error) and the vaccines were administered along with diphtheria toxoid (+) hepatitis b virus vaccine rhbsag (yeast) (+) hib conj vaccine (ompc) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (vero) (+) tetanus toxoid (VAXELIS) (wrong product administered, extra dose administered), on 20-DEC-2021. The medical assistant immediately reported to provider after vaccines were administered. The nurse practitioner reported that poison control and the company was notified: the Toxicologist and the physician with the poison control alone with the company representative reported that hepatitis B to be a very safety vaccine with no expected adverse events, for receiving an extra dose simultaneously. The nurse practitioner spoke with the paternal grandmother and the mom regarding with the information received. It was stated that the patient was that the patient to be sleeping comfortably. No reports of fever or significant changes behaviors reported by the mother and maternal grad mother. The mother was advised to monitor and call if changes in behaviors, redness to injection site and fever would be presented.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
ROTATEQ; PREVENAR 13
Allergien
-
Vorherige Impfungen
-

VAERS 1995125

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
TX
Alter
0,2
Geschlecht
U
Eingang
31.12.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Wrong product administered

Symptomtext

Patient inadivertently admnistered Vaxelis and Engerix; This non-serious spontaneous safety report with the following reference numbers #02078030 and #02078019 was received by a partner on 20-DEC-2021 and forwarded to Agency on 21-DEC-2021 from a health care professional. The causal relationship between Vaxelis and the reported event "Patient inadvertently administered Vaxelis and Engerix" was assessed as not applicable due to the nature of the event. Further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1995123

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
AL
Alter
-
Geschlecht
F
Eingang
31.12.2021
Impfdatum
10.11.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Temperature excursion; This spontaneous non-serious safety report was received on 03-Dec-2021 via Fax by the reporter, from a nurse. A source case was databased with the following number: MCM-002828. Due to the nature of the event (temperature excursion only), the causality between the event and Vaxelis was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1995122

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
ME
Alter
0,2
Geschlecht
F
Eingang
31.12.2021
Impfdatum
22.11.2021
Beginn
22.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Patient received Vaxelis plus PEDVAXHIB in error. PREVENAR was intended to be given instead of PEDVAX; Received 2 doses of HIB (Vaxelis and PEDVAXHIB); This spontaneous safety report was received by the partner on 22-Nov-2021 and forwarded on 23-Nov-2021 from a health care professional. Due to the nature of the event, the causality between "patient received Vaxelis plus PedvaxHIB in error" and Vaxelis was not applicable. No further information is expected. FOLLOW-UP INFORMATION was received by partner on 02-DEC-2021 and forwarded on 03-DEC-2021 and ADDITIONAL INFORMATION was received by partner on 06-DEC-2021 and forwarded on the same date. A 2-month-old female patient was vaccinated with Vaxelis (batch# U7124AA) and PEDVAXHIB (batch# T042015) in error. The reporter stated that Prevnar 13 was intended to be given instead of PEDVAXHIB. Therefore, the patient accidentally received 2 doses of HIB. No adverse event was experienced by the patient. Due to the nature of the event, the causality between "received 2 doses of HIB (Vaxelis and PEDVAXHIB)" and Vaxelis is not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Prophylaxis; Weight abnormal
Andere Medikamente
SIMETHICONE
Allergien
-
Vorherige Impfungen
-

VAERS 1995120

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
AL
Alter
-
Geschlecht
F
Eingang
31.12.2021
Impfdatum
16.11.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

First dose received at 1 year and 2 months; Temperature excursion; This spontaneous safety report was received by the partner on 29-Oct-2021 and forwarded on 1-Nov-2021 from a consumer. This case was considered non-valid due to no patient identifiers (temperature excursion only). Due to the nature of the event, the causality between the event and Vaxelis was not applicable. No further information is expected. FOLLOW-UP INFORMATION was forwarded on 03-Dec-2021 from a nurse. Case became valid since patient identifiers were provided. Reporter was not contacted by the patient's parent regarding any adverse event experienced. No treatment was provided to the patient. Due to the nature of the event, the causality between the event of First dose received at 1 year and 2 months and Vaxelis was not applicable. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1995119

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
CA
Alter
0,2
Geschlecht
M
Eingang
31.12.2021
Impfdatum
13.10.2021
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Gait disturbance Lethargy

Symptomtext

Extremities limp; Lethargic; This spontaneous safety report was received by the Regulatory Authority on 25-OCT-2021 and forwarded to Agency on 27-OCT-2021 from a nurse. The reporter did not provide an assessment of the causal relationship between Vaxelis and the events lethargy and gait disturbance. No further information is expected since the reporter denied consent to be contacted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Gait disturbance
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1995118

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
31.12.2021
Impfdatum
13.10.2021
Beginn
13.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Lethargy

Symptomtext

Lethargic for few minutes; This non-serious spontaneous safety report was received by a partner on 25-OCT-2021 and forwarded on 26-OCT-2021 from a nurse. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of two month old baby received a dose of Vaxelis and had a reaction. Further information is expected. FOLLOW-UP INFORMATION was forwarded on 12-NOV-2021 from a nurse. The case is maintained as non-serious. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported event of Lethargic for few minutes. No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lethargy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
VITAMIN D NOS
Allergien
-
Vorherige Impfungen
-

VAERS 1919182

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U7124AA

gering
Staat
ME
Alter
0,2
Geschlecht
U
Eingang
03.12.2021
Impfdatum
22.11.2021
Beginn
22.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event Wrong product administered

Symptomtext

no additional adverse events reported; patient received V AXELIS plus PEDV AXHIB today in error; received VAXELIS plus PEDVAXHIB today in error / PREVNAR was intended to be given instead of PEDVAXHIB / this was a general human error; This spontaneous report was received from a certified medical assistant and refers to a 2-month-old patient of an unknow gender. No information regarding the patient's medical history or concurrent condition was provided. Her concomitant medications included Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ). On 22-NOV-2021, the patient received diphtheria toxoid (+) hepatitis B virus vaccine rHBsAg (yeast) (+) Hib conj vaccine (OMPC) (+) pertussis acellular 5-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid (VAXELIS) lot # U7124AA was confirmed to be valid, expiration date 13-JUL-2024, 1 dose (exact dose, route and site of administration were not reported) and Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) lot # T042015 was confirmed to be valid, expiration date 23-JUL-2023, 1 dose (exact dose, route and site of administration were not reported) both for prophylaxis, reported as in error. Pneumococcal vaccine conj 7v (crm197) (PREVNAR) was intended to be given instead of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) and there was nothing regarding packaging that caused this error. It was reported as a general human error (wrong product administered, accidental overdose). No further information was provided. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
ROTATEQ
Allergien
-
Vorherige Impfungen
-

VAERS 1801803

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
WA
Alter
0,1
Geschlecht
M
Eingang
20.10.2021
Impfdatum
20.10.2021
Beginn
20.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Wrong product administered

Symptomtext

Patient came in for a well child check today and the provider ordered the administration of Vaxelis, PCV-13, and Rotavirus vaccine. While I was taking these out of the fridge, I got distracted and pulled out Hep B by mistake instead of rotavirus. I administered Vaxelis, Hep B, and PCV. Within one minute of administration, I realized that I gave Hep B by mistake and forgot to administer the rotavirus vaccine. I immediately informed the provider, and she spoke with the patient's mother. Patient did not experience any symptoms or signs while in the office, and the provider advised mother to monitor for any concerning signs or symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 1773570

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge U7124AA

gering
Staat
FL
Alter
-
Geschlecht
M
Eingang
09.10.2021
Impfdatum
08.09.2021
Beginn
08.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

A 16 year old patient received a VAXELIS vaccination in the office on 08SEP2021; This non-serious spontaneous safety report was received by a partner on 15-SEP-2021 and forwarded to Agency on 16-SEP-2021 from a nurse. The causal relationship between Vaxelis and the reported event: A 16-year-old patient received a VAXELIS vaccination in the office on 08-SEP-2021 is assessed as not applicable due to the nature of the event. No further information is expected

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
MMRVAXPRO
Allergien
-
Vorherige Impfungen
-